Apoptosis regulatory network

The apoptosis regulatory network is a complex system of biochemical pathways that orchestrate programmed cell death, a process vital for development, immune system function, and the elimination of damaged cells (NIH, 2023). This network is primarily categorized into the intrinsic pathway, which is regulated by the BCL-2 family of proteins at the mitochondrial level, and the extrinsic pathway, which is activated by extracellular death ligands binding to TNF-family receptors (StatPearls, 2023). Both pathways culminate in the activation of caspases, specialized proteases that execute cell death by cleaving specific cellular substrates. Dysregulation of this network is a fundamental driver of disease; for example, the inhibition of apoptosis allows cancer cells to survive and proliferate despite genomic instability, while excessive apoptosis is a hallmark of neurodegenerative diseases like Alzheimer's (PubMed, 2022). Pharmacological intervention in this network often involves small molecules like Venetoclax, which inhibits anti-apoptotic BCL-2 to trigger death in leukemia cells, or IAP antagonists that sensitize cells to pro-apoptotic stimuli (PubChem, 2024). Because this network is central to the survival of all healthy cells, therapeutic targeting requires high specificity to avoid systemic toxicities such as cytopenia or organ damage.

Other names

Programmed cell death pathwayApoptotic signaling cascadeCell death regulatory network

Modulation of the balance between pro-apoptotic and anti-apoptotic proteins, such as the inhibition of BCL-2 family members or the antagonism of Inhibitor of Apoptosis Proteins (IAPs), to restore the cell's natural ability to undergo programmed cell death.